查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046610

非手術隆鼻市場：全球產業規模、市場佔有率、趨勢、機會和預測（按填充劑類型、應用、最終用途和地區分類）、競爭格局（2021-2031 年）

Non-surgical Rhinoplasty Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Filler Type, By Application, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 192 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球非手術隆鼻市場預計將從 2025 年的 8.1931 億美元大幅成長至 2031 年的 13.6426 億美元，複合年成長率為 8.87%。

這種美容手術也被稱為“注射隆鼻”，通常使用注射式皮膚填充劑，例如透明質酸，無需手術即可暫時重塑鼻型。該市場的成長主要得益於消費者對微創美容療法的需求不斷成長，這些療法見效快、恢復期短，且比傳統手術更經濟實惠。根據國際美容整形外科學會 (ISAPS) 2025 年的報告顯示，市場對這類注射療法的需求依然強勁，預計 2024 年全球玻尿酸注射手術量將成長 5.2%，達到約 630 萬例。

市場概覽
預測期 2027-2031
市場規模（2025 年） 8.1931億美元
市場規模（2031年） 1,364,260,000 美元
複合年成長率（2026-2031） 8.87%
快速成長的細分市場 醫療水療中心
最大的市場 北美洲

然而，由於鼻部血管分佈複雜，發生嚴重血管併發症的風險是市場成長的主要障礙。誤注射入血管可能導致組織壞死和永久性失明等嚴重不利事件，這些安全隱患可能會阻礙患者廣泛接受該產品，並導致更嚴格的監管。

市場促進因素

非手術隆鼻市場的主要驅動力是消費者對微創美容手術日益成長的需求。患者越來越傾向於選擇能夠立即改善鼻型，同時避免傳統手術隆鼻漫長恢復期、麻醉風險和高昂費用的治療方法。隨著越來越多的人尋求能夠讓他們立即恢復日常生活的“午休式手術”，這種偏好的轉變正在改變美容醫學領域，並擴大了患者群體，使其不再局限於傳統上選擇手術的人群。美國臉部整形與重組外科學會 (AAFPRS) 於 2025 年 2 月發布的 2024 年會員年度調查數據顯示，2024 年臉部整形外科醫生實施的手術中，80% 為微創手術，凸顯了非手術治療方法的顯著趨勢。患者選擇的這種根本性轉變直接推動了液態隆鼻領域的發展，該領域提供了一種方便、可逆的方法，利用皮膚填充劑來矯正鼻背的輕微隆起和不對稱。

此外，社群媒體和名流文化對美學標準的日益成長的影響，透過提高人們對美容手術的認知度，使臉部輪廓整形手術更加普及，進一步推動了市場滲透。數位平台讓美容資訊觸手可及，潛在患者可以即時查看術前術後對比照片並找到合適的醫生，顯著加快了美容治療的決策流程。根據美國皮膚外科協會 (ASDS) 於 2025 年 7 月發布的《2025 年美容皮膚科手術消費者調查》，近一半的受訪者表示，醫生的社群媒體影響力會影響他們是否預約手術。這種數位曝光增加了診所的客流量，帶動了注射美容行業的顯著收入成長，並促進了隆鼻市場的擴張。例如，高德美公司報告稱，2025 年前三個季度美容注射產品的淨銷售額達到 18.71 億美元，以固定外匯計算年增 10.5%。

市場挑戰

全球非手術隆鼻市場成長的主要障礙之一是嚴重的血管併發症風險。與注射部位較簡單的區域不同，鼻部區域周圍血管密集。這意味著，如果意外將藥物注射到動脈中，可能會導致災難性的副作用，例如組織壞死和永久性失明。應對這些重大風險需要卓越的解剖學知識和精湛的技術，這嚴重限制了能夠進行此項手術的合格醫生數量。醫生們由於擔心訴訟和害怕對患者造成不可逆轉的傷害而猶豫不決，這成為供應瓶頸，直接限制了市場規模。

此外，隨著大眾對這些風險的認知不斷提高，焦慮情緒甚至蔓延到那些原本可能考慮微創隆鼻的潛在患者群體。這種出於安全考量而產生的猶豫態度，阻礙了非手術隆鼻領域充分利用注射美容市場整體繁榮的機會。例如，儘管英國美容整形外科醫師協會 (BAAPS) 預測，到 2025 年，皮膚填充劑市場的整體手術量將大幅增加 27%，但高風險鼻部手術的成長卻受到這些特定安全隱患的限制。因此，血管併發症的持續威脅限制了該市場的潛在成長，使其與低風險美容手術的快速擴張形成鮮明對比。

市場趨勢

由於越來越多的男性患者尋求微創方法來改善臉部輪廓，非手術隆鼻市場正在經歷重大變革。男性通常選擇注射隆鼻來消除鼻樑突出、矯正不對稱或打造更清晰的鼻樑，他們看重的是注射隆鼻的即時效果和比手術更短的恢復期。這種人口結構的變化有效地將市場拓展到傳統女性消費群體之外，從業者也在調整技術以增強男性特徵。根據美國臉部整形與重組外科學會 (AAFPRS) 於 2025 年 2 月發布的 2024 年會員調查報告，92% 的臉部整形外科醫生會接診男性患者，而隆鼻手術是這一不斷成長的細分市場中最受歡迎的手術之一。

同時，複雜美容療法的趨勢正在改變治療方法，從業者越來越注重協調整體臉部輪廓，而不僅僅是矯正個別鼻部問題。臨床醫生通常將非手術隆鼻與下巴填充和下顎輪廓重塑等手術相結合，以實現臉部比例的平衡；這種技術通常被稱為「輪廓整形」。 GLP-1類減重藥物的廣泛使用進一步推動了這一趨勢。這些藥物的使用會減少臉部容量，因此需要進行填充，這反過來又促進了各種注射療法的同步應用。根據國際美容整形外科學會（ISAPS）於2025年7月發布的《2024年全球美容整形手術調查》，臉部脂肪移植增加了19.2%，顯示消費者越來越偏好整體容量恢復，這與「注射隆鼻」市場相輔相成。

目錄

第1章概述

第2章 分析方法

第3章執行摘要

第4章：客戶心聲

第5章：全球非手術隆鼻市場展望

  • 市場規模及預測
    • 以金額為準
  • 市佔率及預測
    • 填充劑的種類（玻尿酸填充劑、CaHA填充劑）
    • 透過應用（鼻樑突出、鼻樑凹陷、輕度鼻部不對稱等）
    • 依最終用途（醫療水療中心、醫院/手術中心、私人診所）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美非手術隆鼻市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲非手術隆鼻市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區非手術隆鼻市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲非手術隆鼻市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲非手術隆鼻市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 企業合併（M&A）
  • 產品發布
  • 近期趨勢

第13章：全球非手術隆鼻市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific, Inc.
  • SKINovative Medical Spa
  • The London Cosmetic Clinic Limited
  • Laser Clinic United Kingdom Management Ltd
  • Therapie Clinic
  • Toronto Cosmetic Clinic Inc.
  • Canada MedLaser, Inc.
  • Skin Vitality Medical Clinic Inc.
  • True Skin & Laser Limited
  • Nova Aesthetic Clinic Ltd
  • VIVA Aesthetics Ltd
  • Piedmont Plastic Surgery & Dermatology PA

第16章 策略建議

第17章：關於TSCI與免責聲明

簡介目錄
Product Code: 16750

The global non-surgical rhinoplasty market is projected to expand significantly, rising from USD 819.31 Million in 2025 to USD 1364.26 Million by 2031, demonstrating an 8.87% Compound Annual Growth Rate. Often called a liquid nose job, this cosmetic procedure involves using injectable dermal fillers, typically hyaluronic acid, to temporarily reshape and contour the nose without surgical intervention. This market growth is largely fueled by increasing consumer preference for minimally invasive aesthetic treatments that offer immediate outcomes, shorter recovery periods, and a more affordable alternative to traditional surgery. As reported by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2025, the demand for these injectable solutions remains strong, with global hyaluronic acid procedures growing by 5.2% in 2024, reaching about 6.3 million treatments.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 819.31 Million
Market Size 2031USD 1364.26 Million
CAGR 2026-20318.87%
Fastest Growing SegmentMedSpa
Largest MarketNorth America

Nevertheless, the market's growth faces a substantial obstacle due to the risk of severe vascular complications arising from the nose's complex blood supply. Accidental injection into a blood vessel can lead to critical adverse effects like tissue necrosis or permanent blindness, generating safety concerns that could hinder broad patient acceptance and encourage more stringent regulatory scrutiny.

Market Driver

The primary driver for the non-surgical rhinoplasty market is the escalating consumer demand for minimally invasive aesthetic procedures. Patients increasingly prefer treatments that deliver immediate enhancements to nasal shape, avoiding the substantial recovery time, anesthesia risks, and financial outlay associated with conventional surgical rhinoplasty. This evolving preference is transforming the aesthetic sector, as more individuals seek "lunchtime procedures" that enable them to quickly resume their daily routines, thereby expanding the patient demographic beyond those typically opting for surgery. Data from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) '2024 Annual Member Survey' in February 2025 revealed that 80 percent of procedures performed by facial plastic surgeons in 2024 were minimally invasive, underscoring this significant shift towards non-surgical alternatives. This fundamental change in patient choice directly boosts the liquid rhinoplasty segment, offering a reversible and convenient method for correcting minor dorsal humps or asymmetries using dermal fillers.

Additionally, the rising impact of social media and celebrity culture on beauty norms further propels market adoption by enhancing the visibility of procedures and normalizing facial adjustments. Digital platforms have made aesthetic information widely accessible, allowing potential patients to see immediate before-and-after results and find practitioners, which considerably speeds up the decision-making process for cosmetic treatments. The American Society for Dermatologic Surgery (ASDS) '2025 Consumer Survey on Cosmetic Dermatologic Procedures' from July 2025 indicated that nearly half of survey participants considered a provider's social media presence influential in their decision to book an appointment. This digital exposure increases patient traffic to clinics, leading to notable financial growth for the broader injectable sector, which in turn supports the expansion of the rhinoplasty market. For instance, Galderma reported injectable aesthetics net sales of $1.871 billion for the first nine months of 2025, marking a 10.5% year-on-year growth at constant currency.

Market Challenge

A significant obstacle to the global non-surgical rhinoplasty market's growth is the risk of severe vascular complications. The nasal area features a terminal vascular supply, unlike simpler injection sites, meaning an accidental intra-arterial injection can lead to disastrous adverse effects such as tissue necrosis and permanent blindness. These considerable risks demand exceptional anatomical expertise and technical accuracy, thereby severely limiting the number of qualified practitioners prepared to perform the procedure. This hesitancy among providers, stemming from fears of litigation and causing irreversible patient harm, creates a bottleneck in supply that directly suppresses market volume.

Moreover, increased public awareness of these dangers generates apprehension among potential patients who might otherwise consider minimally invasive nasal corrections. This safety-induced reluctance prevents the non-surgical rhinoplasty segment from fully leveraging the wider boom in aesthetic injectables. For example, according to the British Association of Aesthetic Plastic Surgeons (BAAPS) in 2025, while the broader dermal filler market saw a substantial 27% increase in procedures, the growth of high-risk nasal applications is inherently constrained by these specific safety concerns. As a result, the persistent threat of vascular compromise places a ceiling on the market's potential, distinguishing it from the rapid expansion observed in less risky cosmetic procedures.

Market Trends

The non-surgical rhinoplasty market is being significantly reshaped by the increasing number of male patients who are seeking minimally invasive ways to refine their facial profiles. Men often opt for liquid rhinoplasty to address dorsal humps, correct asymmetries, or create a more defined nasal bridge, appreciating the immediate outcomes and minimal recovery time compared to surgical options. This demographic shift is effectively expanding the market beyond its traditional female consumer base, with practitioners adapting their techniques to enhance masculine facial features. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) '2024 Annual Member Survey', released in February 2025, reported that 92 percent of facial plastic surgeons treated male patients, with rhinoplasty being among the most requested procedures in this expanding segment.

Simultaneously, the rising trend of combination aesthetic therapies is transforming treatment approaches, as practitioners increasingly focus on achieving comprehensive facial profile harmonization instead of merely correcting isolated nasal concerns. Clinicians are frequently pairing non-surgical rhinoplasty with procedures like chin augmentation and jawline contouring to achieve balanced facial proportions, a practice often referred to as "profiloplasty." This trend is further boosted by the widespread use of GLP-1 weight-loss medications, which necessitates volume restoration to address facial deflation, thus promoting the simultaneous application of various injectable treatments. According to the International Society of Aesthetic Plastic Surgery (ISAPS) '2024 Global Survey on Aesthetic/Cosmetic Procedures' from July 2025, facial fat grafting procedures saw a 19.2% increase, underscoring a growing consumer preference for holistic volumetric rejuvenation that complements the liquid rhinoplasty market.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • SKINovative Medical Spa
  • The London Cosmetic Clinic Limited
  • Laser Clinic United Kingdom Management Ltd
  • Therapie Clinic
  • Toronto Cosmetic Clinic Inc.
  • Canada MedLaser, Inc.
  • Skin Vitality Medical Clinic Inc.
  • True Skin & Laser Limited
  • Nova Aesthetic Clinic Ltd
  • VIVA Aesthetics Ltd
  • Piedmont Plastic Surgery & Dermatology PA

Report Scope

In this report, the Global Non-surgical Rhinoplasty Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-surgical Rhinoplasty Market, By Filler Type

  • Hyaluronic Acid Filler
  • CaHa Filler

Non-surgical Rhinoplasty Market, By Application

  • Convex Nose
  • Indentations of dorsal hump
  • Minor Nasal Asymmetry
  • Others

Non-surgical Rhinoplasty Market, By End-use

  • MedSpa
  • Hospital/Surgery Center
  • HCP-owned Clinic

Non-surgical Rhinoplasty Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-surgical Rhinoplasty Market.

Available Customizations:

Global Non-surgical Rhinoplasty Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Non-surgical Rhinoplasty Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Filler Type (Hyaluronic Acid Filler, CaHa Filler)
    • 5.2.2. By Application (Convex Nose, Indentations of dorsal hump, Minor Nasal Asymmetry, Others)
    • 5.2.3. By End-use (MedSpa, Hospital/Surgery Center, HCP-owned Clinic)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Non-surgical Rhinoplasty Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Filler Type
    • 6.2.2. By Application
    • 6.2.3. By End-use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Non-surgical Rhinoplasty Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Filler Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada Non-surgical Rhinoplasty Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Filler Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico Non-surgical Rhinoplasty Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Filler Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-use

7. Europe Non-surgical Rhinoplasty Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Filler Type
    • 7.2.2. By Application
    • 7.2.3. By End-use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Non-surgical Rhinoplasty Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Filler Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-use
    • 7.3.2. France Non-surgical Rhinoplasty Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Filler Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-use
    • 7.3.3. United Kingdom Non-surgical Rhinoplasty Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Filler Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-use
    • 7.3.4. Italy Non-surgical Rhinoplasty Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Filler Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain Non-surgical Rhinoplasty Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Filler Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-use

8. Asia Pacific Non-surgical Rhinoplasty Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Filler Type
    • 8.2.2. By Application
    • 8.2.3. By End-use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Non-surgical Rhinoplasty Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Filler Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-use
    • 8.3.2. India Non-surgical Rhinoplasty Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Filler Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan Non-surgical Rhinoplasty Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Filler Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea Non-surgical Rhinoplasty Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Filler Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia Non-surgical Rhinoplasty Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Filler Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-use

9. Middle East & Africa Non-surgical Rhinoplasty Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Filler Type
    • 9.2.2. By Application
    • 9.2.3. By End-use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Non-surgical Rhinoplasty Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Filler Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-use
    • 9.3.2. UAE Non-surgical Rhinoplasty Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Filler Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-use
    • 9.3.3. South Africa Non-surgical Rhinoplasty Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Filler Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-use

10. South America Non-surgical Rhinoplasty Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Filler Type
    • 10.2.2. By Application
    • 10.2.3. By End-use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Non-surgical Rhinoplasty Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Filler Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-use
    • 10.3.2. Colombia Non-surgical Rhinoplasty Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Filler Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-use
    • 10.3.3. Argentina Non-surgical Rhinoplasty Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Filler Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Non-surgical Rhinoplasty Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. SKINovative Medical Spa
  • 15.3. The London Cosmetic Clinic Limited
  • 15.4. Laser Clinic United Kingdom Management Ltd
  • 15.5. Therapie Clinic
  • 15.6. Toronto Cosmetic Clinic Inc.
  • 15.7. Canada MedLaser, Inc.
  • 15.8. Skin Vitality Medical Clinic Inc.
  • 15.9. True Skin & Laser Limited
  • 15.10. Nova Aesthetic Clinic Ltd
  • 15.11. VIVA Aesthetics Ltd
  • 15.12. Piedmont Plastic Surgery & Dermatology PA

16. Strategic Recommendations

17. About Us & Disclaimer